| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Jun 20, 2024 | Nkarta, Inc. | Chief Scientific Officer | Sell | 52.5 | -456 | -0.30% | ✗ | $2.6K |
| Feb 12, 2024 | Feb 14, 2024 | Nkarta, Inc. | Chief Scientific Officer | Sell | 45.0 | -4,143 | -2.70% | ✓ | $49.7K |
| Jan 16, 2024 | Jan 18, 2024 | Nkarta, Inc. | Chief Scientific Officer | Sell | 46.3 | -4,560 | -2.88% | ✗ | $39.9K |
| Jun 20, 2023 | Jun 22, 2023 | Nkarta, Inc. | Chief Scientific Officer | Sell | 52.5 | -439 | -0.44% | ✗ | $2.1K |
| Jan 13, 2023 | Jan 18, 2023 | Nkarta, Inc. | Chief Scientific Officer | Sell | 90.0 | +36,385 | 58.52% | ✗ | $6.1K |
| Aug 15, 2022 | Aug 17, 2022 | Nkarta, Inc. | Chief Scientific Officer | Sell | 32.5 | -5,000 | -7.44% | ✓ | $87.7K |
| Aug 2, 2021 | Aug 4, 2021 | Nkarta, Inc. | Chief Scientific Officer | Sell | 28.8 | -3,600 | -7.50% | ✓ | $113.5K |
| May 3, 2021 | May 5, 2021 | Nkarta, Inc. | Chief Scientific Officer | Sell | 37.5 | -3,600 | -3.79% | ✓ | $113.9K |
| Feb 1, 2021 | Feb 3, 2021 | Nkarta, Inc. | Chief Scientific Officer | Sell | 35.0 | -6,400 | -4.29% | ✓ | $251.2K |